Quest Diagnostics (DGX) Tops Q4 EPS by 24c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/10/2026

1. SPY
2. USO
3. META
4. MSFT
5. MU

6. COST
7. IONS
8. RXT
9. AAPL
10. CME

Get Alerts DGX Hot Sheet

Price: $208.05 -0.08%

EPS Growth %: +7.6%

Financial Fact:
Net income: 1.37

Today's EPS Names:
CCEL, SLP, TMQ, More

Join SI Premium – FREE

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $4.48, $0.24 better than the analyst estimate of $4.24. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.93 billion.

Outlook for First Half of 2021

The company estimates its first half 2021 results as follows:

	Low	High
Net revenues	$4.85 billion	$5.15 billion
Net revenues increase	32.9%	41.1%
Reported diluted EPS	$5.07	6.07
Adjusted diluted EPS	$5.90	$6.90
Cash provided by operations	At least $800 million
Capital expenditures	Approximately $200 million

Note on Non-GAAP Financial Measures

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!